WallStreetZenWallStreetZen

NASDAQ: RKDA
Arcadia Biosciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for RKDA

Based on 1 analyst offering 12 month price targets for Arcadia Biosciences Inc.
Min Forecast
$6.00+113.52%
Avg Forecast
$6.00+113.52%
Max Forecast
$6.00+113.52%

Should I buy or sell RKDA stock?

Based on 1 analyst offering ratings for Arcadia Biosciences Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their RKDA stock forecasts and price targets.

RKDA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-08-21

1 of 1

Forecast return on equity

Is RKDA forecast to generate an efficient return?
Company
1.4%
Industry
16.08%
Market
49.92%
RKDA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is RKDA forecast to generate an efficient return on assets?
Company
0.94%
Industry
7.57%
RKDA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

RKDA earnings per share forecast

What is RKDA's earnings per share in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$1.70
Avg 2 year Forecast
$0.12

RKDA revenue forecast

What is RKDA's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$5.4M+1.46%
Avg 2 year Forecast
$6.6M+22.99%
RKDA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

RKDA revenue growth forecast

How is RKDA forecast to perform vs Packaged Foods companies and vs the US market?
Company
1.46%
Industry
3.02%
Market
10.09%
RKDA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
RKDA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

RKDA vs Food Stocks

TickerPricePrice TargetUp/downsideConsensus
RKDA$2.81$6.00+113.52%Buy
BTTR$1.81$10.00+452.49%Strong Buy
BON$1.89N/AN/A
SNAX$1.56N/AN/A
NUZE$0.42N/AN/A
View Top Food Stocks

Arcadia Biosciences Stock Forecast FAQ

Is Arcadia Biosciences Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: RKDA) stock is to Buy RKDA stock.

Out of 1 analyst, 0 (0%) are recommending RKDA as a Strong Buy, 1 (100%) are recommending RKDA as a Buy, 0 (0%) are recommending RKDA as a Hold, 0 (0%) are recommending RKDA as a Sell, and 0 (0%) are recommending RKDA as a Strong Sell.

If you're new to stock investing, here's how to buy Arcadia Biosciences stock.

What is RKDA's earnings growth forecast for 2024-2025?

(NASDAQ: RKDA) Arcadia Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Packaged Foods industry's average forecast earnings growth rate of 49.8%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 31.31%.

Arcadia Biosciences's earnings in 2024 is -$6,782,000.On average, 1 Wall Street analyst forecast RKDA's earnings for 2024 to be -$2,316,828, with the lowest RKDA earnings forecast at -$2,316,828, and the highest RKDA earnings forecast at -$2,316,828.

In 2025, RKDA is forecast to generate $163,541 in earnings, with the lowest earnings forecast at $163,541 and the highest earnings forecast at $163,541.

What is RKDA's revenue growth forecast for 2024-2025?

(NASDAQ: RKDA) Arcadia Biosciences's forecast annual revenue growth rate of 1.46% is not forecast to beat the US Packaged Foods industry's average forecast revenue growth rate of 3.02%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.09%.

Arcadia Biosciences's revenue in 2024 is $5,328,000.On average, 1 Wall Street analysts forecast RKDA's revenue for 2024 to be $7,367,513, with the lowest RKDA revenue forecast at $7,367,513, and the highest RKDA revenue forecast at $7,367,513.

In 2025, RKDA is forecast to generate $8,930,691 in revenue, with the lowest revenue forecast at $8,930,691 and the highest revenue forecast at $8,930,691.

What is RKDA's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: RKDA) forecast ROA is 0.94%, which is lower than the forecast US Packaged Foods industry average of 7.57%.

What is RKDA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year RKDA price target, the average RKDA price target is $6.00, with the highest RKDA stock price forecast at $6.00 and the lowest RKDA stock price forecast at $6.00.

The Wall Street analyst predicted that Arcadia Biosciences's share price could reach $6.00 by Aug 21, 2025. The average Arcadia Biosciences stock price prediction forecasts a potential upside of 113.52% from the current RKDA share price of $2.81.

What is RKDA's Earnings Per Share (EPS) forecast for 2024-2025?

(NASDAQ: RKDA) Arcadia Biosciences's current Earnings Per Share (EPS) is -$4.88. On average, analysts forecast that RKDA's EPS will be -$1.70 for 2024, with the lowest EPS forecast at -$1.70, and the highest EPS forecast at -$1.70. In 2025, RKDA's EPS is forecast to hit $0.12 (min: $0.12, max: $0.12).

What is RKDA's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: RKDA) forecast ROE is 1.4%, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.